About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Flow Cytometry in Oncology Market Size, Competitive Landscape and Report 2031
Flow Cytometry in Oncology Market

Flow Cytometry in Oncology Market Size, Share & Trends Analysis Report By Product Type (Software, Reagents and Consumables, Instruments, Assays and Kits), By Technology (Bead-Based, Cell-Based), By Type of Cancer (Solid Tumors, Hematological Malignancies), By Applications (Treatment Monitoring, Clinical Applications, Screening and Diagnostics, Translational Research), By End-User (Diagnostic Laboratories, Hospitals and Healthcare Centers, Academic and Research Institutions, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI54215DR
Author : Straits Research
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Flow Cytometry in Oncology Market Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Software
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Instruments
        1. By Value
      5. Assays and Kits
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Bead-Based
        1. By Value
      3. Cell-Based
        1. By Value
    4. By Type of Cancer
      1. Introduction
        1. Type of Cancer By Value
      2. Solid Tumors
        1. By Value
      3. Hematological Malignancies
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment Monitoring
        1. By Value
      3. Clinical Applications
        1. By Value
      4. Screening and Diagnostics
        1. By Value
      5. Translational Research
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Hospitals and Healthcare Centers
        1. By Value
      4. Academic and Research Institutions
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Software
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Instruments
        1. By Value
      5. Assays and Kits
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Bead-Based
        1. By Value
      3. Cell-Based
        1. By Value
    4. By Type of Cancer
      1. Introduction
        1. Type of Cancer By Value
      2. Solid Tumors
        1. By Value
      3. Hematological Malignancies
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment Monitoring
        1. By Value
      3. Clinical Applications
        1. By Value
      4. Screening and Diagnostics
        1. By Value
      5. Translational Research
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Hospitals and Healthcare Centers
        1. By Value
      4. Academic and Research Institutions
        1. By Value
      5. Others
        1. By Value
    7. U.S.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Software
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Instruments
          1. By Value
        5. Assays and Kits
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Bead-Based
          1. By Value
        3. Cell-Based
          1. By Value
      3. By Type of Cancer
        1. Introduction
          1. Type of Cancer By Value
        2. Solid Tumors
          1. By Value
        3. Hematological Malignancies
          1. By Value
      4. By Applications
        1. Introduction
          1. Applications By Value
        2. Treatment Monitoring
          1. By Value
        3. Clinical Applications
          1. By Value
        4. Screening and Diagnostics
          1. By Value
        5. Translational Research
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Hospitals and Healthcare Centers
          1. By Value
        4. Academic and Research Institutions
          1. By Value
        5. Others
          1. By Value
    8. Canada
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Software
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Instruments
        1. By Value
      5. Assays and Kits
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Bead-Based
        1. By Value
      3. Cell-Based
        1. By Value
    4. By Type of Cancer
      1. Introduction
        1. Type of Cancer By Value
      2. Solid Tumors
        1. By Value
      3. Hematological Malignancies
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment Monitoring
        1. By Value
      3. Clinical Applications
        1. By Value
      4. Screening and Diagnostics
        1. By Value
      5. Translational Research
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Hospitals and Healthcare Centers
        1. By Value
      4. Academic and Research Institutions
        1. By Value
      5. Others
        1. By Value
    7. U.K.
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Software
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Instruments
          1. By Value
        5. Assays and Kits
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Bead-Based
          1. By Value
        3. Cell-Based
          1. By Value
      3. By Type of Cancer
        1. Introduction
          1. Type of Cancer By Value
        2. Solid Tumors
          1. By Value
        3. Hematological Malignancies
          1. By Value
      4. By Applications
        1. Introduction
          1. Applications By Value
        2. Treatment Monitoring
          1. By Value
        3. Clinical Applications
          1. By Value
        4. Screening and Diagnostics
          1. By Value
        5. Translational Research
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Hospitals and Healthcare Centers
          1. By Value
        4. Academic and Research Institutions
          1. By Value
        5. Others
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Software
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Instruments
        1. By Value
      5. Assays and Kits
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Bead-Based
        1. By Value
      3. Cell-Based
        1. By Value
    4. By Type of Cancer
      1. Introduction
        1. Type of Cancer By Value
      2. Solid Tumors
        1. By Value
      3. Hematological Malignancies
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment Monitoring
        1. By Value
      3. Clinical Applications
        1. By Value
      4. Screening and Diagnostics
        1. By Value
      5. Translational Research
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Hospitals and Healthcare Centers
        1. By Value
      4. Academic and Research Institutions
        1. By Value
      5. Others
        1. By Value
    7. China
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Software
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Instruments
          1. By Value
        5. Assays and Kits
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Bead-Based
          1. By Value
        3. Cell-Based
          1. By Value
      3. By Type of Cancer
        1. Introduction
          1. Type of Cancer By Value
        2. Solid Tumors
          1. By Value
        3. Hematological Malignancies
          1. By Value
      4. By Applications
        1. Introduction
          1. Applications By Value
        2. Treatment Monitoring
          1. By Value
        3. Clinical Applications
          1. By Value
        4. Screening and Diagnostics
          1. By Value
        5. Translational Research
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Hospitals and Healthcare Centers
          1. By Value
        4. Academic and Research Institutions
          1. By Value
        5. Others
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Software
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Instruments
        1. By Value
      5. Assays and Kits
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Bead-Based
        1. By Value
      3. Cell-Based
        1. By Value
    4. By Type of Cancer
      1. Introduction
        1. Type of Cancer By Value
      2. Solid Tumors
        1. By Value
      3. Hematological Malignancies
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment Monitoring
        1. By Value
      3. Clinical Applications
        1. By Value
      4. Screening and Diagnostics
        1. By Value
      5. Translational Research
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Hospitals and Healthcare Centers
        1. By Value
      4. Academic and Research Institutions
        1. By Value
      5. Others
        1. By Value
    7. UAE
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Software
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Instruments
          1. By Value
        5. Assays and Kits
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Bead-Based
          1. By Value
        3. Cell-Based
          1. By Value
      3. By Type of Cancer
        1. Introduction
          1. Type of Cancer By Value
        2. Solid Tumors
          1. By Value
        3. Hematological Malignancies
          1. By Value
      4. By Applications
        1. Introduction
          1. Applications By Value
        2. Treatment Monitoring
          1. By Value
        3. Clinical Applications
          1. By Value
        4. Screening and Diagnostics
          1. By Value
        5. Translational Research
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Hospitals and Healthcare Centers
          1. By Value
        4. Academic and Research Institutions
          1. By Value
        5. Others
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Product Type
      1. Introduction
        1. Product Type By Value
      2. Software
        1. By Value
      3. Reagents and Consumables
        1. By Value
      4. Instruments
        1. By Value
      5. Assays and Kits
        1. By Value
    3. By Technology
      1. Introduction
        1. Technology By Value
      2. Bead-Based
        1. By Value
      3. Cell-Based
        1. By Value
    4. By Type of Cancer
      1. Introduction
        1. Type of Cancer By Value
      2. Solid Tumors
        1. By Value
      3. Hematological Malignancies
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Treatment Monitoring
        1. By Value
      3. Clinical Applications
        1. By Value
      4. Screening and Diagnostics
        1. By Value
      5. Translational Research
        1. By Value
    6. By End-User
      1. Introduction
        1. End-User By Value
      2. Diagnostic Laboratories
        1. By Value
      3. Hospitals and Healthcare Centers
        1. By Value
      4. Academic and Research Institutions
        1. By Value
      5. Others
        1. By Value
    7. Brazil
      1. By Product Type
        1. Introduction
          1. Product Type By Value
        2. Software
          1. By Value
        3. Reagents and Consumables
          1. By Value
        4. Instruments
          1. By Value
        5. Assays and Kits
          1. By Value
      2. By Technology
        1. Introduction
          1. Technology By Value
        2. Bead-Based
          1. By Value
        3. Cell-Based
          1. By Value
      3. By Type of Cancer
        1. Introduction
          1. Type of Cancer By Value
        2. Solid Tumors
          1. By Value
        3. Hematological Malignancies
          1. By Value
      4. By Applications
        1. Introduction
          1. Applications By Value
        2. Treatment Monitoring
          1. By Value
        3. Clinical Applications
          1. By Value
        4. Screening and Diagnostics
          1. By Value
        5. Translational Research
          1. By Value
      5. By End-User
        1. Introduction
          1. End-User By Value
        2. Diagnostic Laboratories
          1. By Value
        3. Hospitals and Healthcare Centers
          1. By Value
        4. Academic and Research Institutions
          1. By Value
        5. Others
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Flow Cytometry in Oncology Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Agilent Technologies, Inc
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Apogee Flow Systems Ltd
    3. Becton
    4. Dickinson and Company
    5. bioAffinity Technologies, Inc
    6. Bio-Rad Laboratories, Inc
    7. Bio-Techne Corporation
    8. Cytek Biosciences
    9. Cytognos
    10. S.L
    11. Danaher Corporation
    12. Miltenyi Biotec B.V. & Co. KG
    13. Luminex Corporation
    14. NeoGenomics Laboratories Inc
    15. Sony Corporation
    16. Thermo Fisher Scientific Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Global Flow Cytometry Market Size The global flow cytometry market size was valued at USD 4.79 billion in 2024 and is projected to grow from USD 5.01 billion in 2025 to reach USD 10.61 billion by 2033, growing at a CAGR of 9.8% during the forecast p
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright . All rights Reserved.